Neopharm Group Overview
Neopharm is a family of companies that engage in the research and development, manufacturing, marketing, sales, and distribution of a broad range of products in the healthcare market in more than 60 countries worldwide. The Neopharm Group operates in three major segments: pharmaceutical, consumer healthcare, and medical devices.
Latest News
| Sector | Health Tech & Life Sciences |
Funding
| Total funding | Undisclosed |
| Last funding | Undisclosed |
| Stage | Mature |
| Rounds | 0 |
| Investors | 0 |
Team Members
4
Employees: 51-200
Web & Social Links
| Website | neopharmgroup.com |
Locations
HaShiloah St 6, Petah Tikva, Israel
Photos & Videos
No files yet
Neopharm Group Business
Sector
Health Tech & Life SciencesMedical DevicesPharma & Medical BiotechnologyTarget Customer
Healthcare & Life SciencesHealthcareProvidersLife SciencesBiotechnologyPharmaceuticalsMedical Devices IndustryMedical ProductsMedical EquipmentCore Technology
—Tags (1)
pharmaceuticalsNeopharm Group Financials
Neopharm Group Lifecycle
Neopharm Group News
1 articleNeopharm Group Team
Employee Info
| Employees (range) | 51-200 |
| Exact count | 161 |
| Team members | 4 |
Similar Companies
Similar companies data is computed dynamically and not stored in the entity profile. This section requires implementing a similarity query (e.g. by classification overlap, sector, district).
This entity has 12 classification IDs that could be used for matching.
Neopharm Group Internal
Recent Updates
No update log entries.
Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.
Admin Info
| Confidence | 80/100 |
| Missing | tags, video or image, funding rounds, markets, not claimed |
| BI Verification | Matan Eblagon |
| Registrar ID | 512420555 |
| Creator | Matan Eblagon |
| Creator email | matane@sncentral.org |
| Last updater | Matan Eblagon |
| Updater email | matane@sncentral.org |
| Last update | 2023-05-11T00:00:00.000Z |
| Created | 2023-03-19T00:00:00.000Z |